MendelR integrates multi-omics databases and advanced analytical methods for robust causal inference analysis. It enables large-scale systems-level analyses and high-throughput screening of causal relationships across different biological layers.
A new study published in iMetaMed uses single-cell Raman spectroscopy to track biochemical changes in mouse oocytes as they age, revealing a decline in metabolic maturity. The research suggests that mitochondrial dysfunction plays a key role in the age-related decline of egg cell quality.
The Rad51 protein plays a crucial role in connecting DNA damage repair, tumor progression, and immune regulation. Dysregulation of Rad51 can alter immunogenicity of tumor cells, affecting cGAS-STING innate immune pathway and Programmed Death-Ligand 1 (PD-L1) expression.
This study analyzed the temporal evolution of three LLMs in oncology, finding that subjective questions degrade faster over time than objective queries. The results highlight the need for ongoing performance monitoring and strategies to integrate up-to-date clinical data for safe and reliable AI deployment in cancer care.
The cloud-based GWAS platform integrates major international databases and streamlines genetic analyses with its scalable resources, optimized algorithms, and robust security features. It accelerates discoveries in precision medicine by overcoming traditional barriers to genomic research.
Computationally predicted protein target sites offer a strategic pathway for disease mechanism elucidation and therapeutic acceleration. Advanced frameworks like Markov State Models and Gaussian accelerated MD enable exploration of long-timescale dynamics.
Researchers investigate Alzheimer's disease progression, revealing disrupted organizational patterns in the brain's precuneus and default mode network. Gray matter volume reductions and functional connectivity abnormalities are linked to cognitive decline, dementia severity, and functional impairments.
Malignant mesothelioma of the tunica vaginalis testis has a global incidence of 0.54-0.95 per 10 million person-years, with asbestos exposure being a major risk factor. The expert consensus aims to shift clinical practice from empirical treatment to evidence-based, personalized care for patients with this rare disease.
CRISPR enables precise targeting of oncogenes and reactivation of tumor suppressor genes, and is pivotal in dissecting the tumor microenvironment to enhance anti-tumor immunity. Next-generation tools are being developed for easier delivery and optimized efficiency.
Researchers identified TCF/LEF proteins as key regulators of the canonical Wnt pathway, which governs transcription in cancer and fibrotic diseases. The study reveals potential therapeutic targets for treating diverse diseases while avoiding toxicity associated with upstream Wnt inhibition.
A novel graph-enhanced AI framework called RSA-KG was developed to tackle complex, multifactorial cases of recurrent spontaneous abortions. It outperforms existing models by structuring knowledge and enabling multihop reasoning, leading to more accurate diagnoses and treatment plans.
Research on non-histone lactylation in cerebral ischemia-reperfusion injury is at a preliminary stage, but this review aims to bridge knowledge gaps by exploring its dynamic alterations and regulatory mechanisms. Strategies for site identification and potential therapeutic interventions are also discussed.
This study examines the global, regional, and national burden of cancer among individuals aged 60-94 worldwide. The analysis reveals significant disparities in cancer prevalence, mortality, and disability-adjusted life years (DALY) among elderly populations.
The CPA journal was honored with the 'Great Progress Award' for its significant advancements in journal development and academic dissemination. Its impact factor has doubled to 1.5, reflecting substantial increases in academic influence and recognition.
AI accelerates pathogen evolution prediction and enables new target discovery, facilitating efficient compound design and optimization. This technology compresses the development cycle by focusing on key applications like phenotype-driven target identification and validation.
Large language models could streamline clinical trial processes by refining eligibility criteria and tailoring informed consent materials. They also show potential for faster, more accurate patient screening and real-time safety monitoring.
Researchers have identified a novel biomarker, DKK1 to CALML5 ratio (DC score), predicting patient prognosis and response to immunotherapy in head and neck squamous cell carcinoma. The DC score also correlates with incomplete pathological response and poorer overall survival.
Phenolic acids have been identified as a promising therapeutic frontier for vascular cognitive impairment, exhibiting potent antioxidant, anti-inflammatory, and neuroprotective effects.
This study found that TNF-α is highly expressed in asthma patients' airways and induces bronchial fibroblasts to produce inflammatory cytokines. The upregulated genes are closely related to eosinophil or neutrophil inflammation, indicating a role for bronchial fibroblasts in airway inflammation.
The bregr R package streamlines the process of analyzing large-scale biomedical data by automating model fitting, extracting tidy results, and providing publication-quality visualizations. This results in enhanced efficiency and scalability for researchers, while maintaining reproducibility and accuracy.
The E2E R package offers a comprehensive framework for ensemble learning, combining multiple base models to enhance prediction accuracy and robustness. It achieved excellent performance on imbalanced datasets, outperforming mature algorithms in Python.
Researchers identified five hub genes with high diagnostic performance, showing significant sensitivity and specificity in distinguishing OA from control samples. They predicted targeted drugs with excellent binding interactions, potentially offering therapeutic benefits for OA patients.
Researchers have made significant strides in understanding osteoarthritis by identifying five hub genes that show high diagnostic performance. These genes, including IGKC, MCL1, and NFKBIA, are predicted to be targeted by several drugs, including rapamycin and Sodium_salicylate.
Published by Far Publishing Company, Current Pharmaceutical Analysis (CPA) provides a platform for researchers to share their latest findings. The journal focuses on drug discovery to clinical application, aiming to advance every aspect of pharmaceutical science.
Researchers identified citronellyl butyrate and other compounds with high binding affinity to DPP-4, suggesting strong inhibitory potential. The compounds' favorable pharmacokinetic properties, such as high absorption and blood-brain barrier permeability, make them promising candidates for antidiabetic treatments.
Current Molecular Pharmacology is a prominent journal covering mechanisms of new drugs, innovative technologies, and omics applications. It has an impact factor of 2.9 and CiteScore of 5.5, ranking Q2 in pharmacology.
HPV integration in high-risk types like HPV18, 31, and 45 approaches 100% in malignant lesions, driving clonal expansion and genomic instability. Integration-based biomarkers are being evaluated to enhance diagnostic accuracy and patient management.
This study analyzed adverse events following HPV vaccination in male recipients of Gardasil 9 and Gardasil. The results showed that most AEFI reports occurred within 30 days post-vaccination, with a lower cumulative incidence for Gardasil 9, suggesting a potentially more favourable safety profile.
FigureYa is a modular visualization framework that eliminates technical barriers to scientific visualization. It offers pre-configured code templates, sample datasets, and bilingual annotations, enabling users with minimal programming background to generate professional-grade visualizations.
The complexity of the tumor microenvironment hinders therapeutic intervention; nanomedicine emerges as a promising tool to modulate it. Researchers have systematically reviewed four primary mechanisms by which nanomaterials enhance antitumor therapy, including modulation of complex components within the TME.
The human microbiome influences cancer growth and treatment outcomes through specific microbial signatures, metabolites, and biomarkers. The review highlights emerging interventions such as probiotics and engineered microbial therapies to improve precision oncology and non-invasive diagnostics.
A global study using disability data identified vulnerable populations at risk for long COVID, particularly in areas with underreported post-COVID conditions. The researchers call for urgent expansion of long COVID care and integration of disability data into early warning systems to address global health inequalities.
The study evaluates five generative AI models for optimizing biosafety laboratory management, achieving excellent performance on text-based questions. The AI-driven system enables real-time laboratory monitoring, predictive maintenance, and improved biosafety training through automatic generation of customized materials.
A new RP-HPLC method has been developed and validated for the analysis of orlistat, a widely used anti-obesity drug. The method ensures accurate quantification and is fully compliant with International Council for Harmonisation (ICH) guidelines, reducing solvent use and analysis time.
A comprehensive review of pyridazinone derivatives reveals their therapeutic potential in treating multiple diseases. The compounds have shown anticancer, anti-inflammatory, antimicrobial, and neuroprotective properties, making them a valuable target for drug discovery.
A groundbreaking study has identified key genes and compounds in Rhizoma Coptidis that may modulate cell cycle dysfunction in tendinopathy. The research highlights the potential of traditional Chinese medicine in modern therapeutics, with a focus on experimental validation in animal models and clinical trials.
A multicenter study of 4,257 pneumonia patients reveals three distinct clinical phenotypes with varying responses to corticosteroid therapy. Precisely dosed intravenous methylprednisolone improves survival rates in the most severe group, Phenotype C.
Large language models are transforming drug development by identifying promising candidates and analyzing complex data. These advancements hold promise for saving years of development time in drug repurposing and improving safety monitoring in clinical trials.
FastUKB streamlines UK Biobank research workflows with bulk data extraction and intelligent data processing capabilities. It offers advanced statistical analysis tools, including linear regression and polygenic risk scoring, through a user-friendly interface.
Tumor electrophysiological abnormalities drive malignancy through membrane potential dysregulation, ion channel network remodeling, and microenvironmental signaling interactions. Precision therapies targeting these abnormalities have advanced significantly, including electric field therapies and nanoparticle systems.
The 'slicing + dictionary' method reduces resource requirements, improves query efficiency, and enhances flexibility in medical big data analysis. It overcomes limitations of traditional methods by empowering ordinary researchers.
Contamination from laboratory reagents, particularly silica membranes, can create false virus-host associations in metagenomic sequencing data. Researchers developed the PVDDC database to standardize virus-host relationships and trace contamination.
Large language models are revolutionizing bioinformatics research by decoding complex biological data, predicting protein structures, and identifying disease-linked genes. The models' five core strengths include enabling breakthroughs in protein analysis, drug discovery, and genomic research.
Researchers synthesized AI-driven analysis of protein structures to predict drug interactions and optimize synergy. This fusion approach aims to solve drug resistance, reduce side effects, and guide personalized treatment in precision medicine.
Exosomes from tumors can promote cancer cell proliferation and angiogenesis, while also suppressing immune responses by delivering immunoinhibitory ligands. The review highlights the potential of exosome-based therapeutics to restore antitumor immunity.
Immune-related adverse events (irAEs) are a significant concern in cancer immunotherapy, arising from the overactivation of the immune system. Clinical characteristics include multi-organ involvement, heterogeneous onset times, and distinct toxicity profiles among different ICIs.
Researchers identify key apoptotic signaling pathways involved in glucocorticoid-induced osteonecrosis, including CD95/CD95L and PI3K/Akt survival pathways. They also highlight genetic biomarkers and novel therapeutic strategies, such as targeting specific molecular pathways with natural compounds.
A recent study has found that rheumatoid arthritis (RA) is a causal factor for idiopathic pulmonary fibrosis (IPF), while IPF is not causally related to RA. The research also identified shared biomarkers, including CCL2 and CXCL2, which were significantly elevated in RA patients.
A comprehensive analysis reveals how cancer cells hijack immune checkpoints on NK cells to disable the body's frontline defense system. Anti-TIGIT antibodies and CAR-NK innovation offer promising breakthroughs in liver cancer trials and acute myeloid leukemia treatment.
This meta-analysis found that FMT combined with ICIs resulted in improved objective response and disease control rates, with an acceptable safety profile. Subgroup analysis revealed a significant association between the combination of anti-PD-1 and anti-CTLA-4 therapies and higher overall response rates.